Cantor Equity Partners VII, Inc.
CAES
$10.07
▲
+0.01
(+0.10%)
at close
6
Visible periods
6
Metrics
Peer-ranked
Benchmarks
Price Chart
insights
Verdict pending
Sync financial data to generate a health grade for this company.
auto_awesome
Analytical Summary
Review the statement evidence below to form a view on CAES.
Market Cap
—
Dividend Yield
—
Revenue Growth
—
Op. Margin
—
ROIC
1.6%
FCF / Share
—
Trailing P/E
—
Price / Book
—
FCF Yield
—
Debt / Equity
—
info
Valuation on last close. End-of-day price, Aug 14, 2026.
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Is capital allocation efficient?
3 metrics
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
1.6%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — | — | — | — |
| Return on Capital (%) (%) |
-0.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — | — |
| Return on Common Equity (%) (%) |
0.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-93%)
|
— | — | — | — | — |
Is the balance sheet risky?
1 metrics
How resilient is the balance sheet?
1 metrics
⌨️ Keyboard Shortcuts
/ Search
Esc Clear
A Annual
Q Quarterly
1-7 Jump to category
R Reset
Secondary lens
Benchmark Lens
Compare CAES against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare CAES against peers after checking the statement evidence.
Compare CAES with peers
Stack CAES against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced today